U.S. Food and Drug Administration
The biggest bit of marijuana industry news in the week ending August 12 was that the DEA rejected a call to loosen federal restrictions on marijuana.
6 years ago
Last Updated: 2 years ago
AcelRx Pharmaceuticals announced an update on the timing and potential content of its resubmission of the New Drug Application (NDA) for Zalviso.
7 years ago
Source: ThinkstockOncolytics Biotech Inc. (NASDAQ: ONCY) announced that the U.S. Food and Drug Administration (FDA) granted Orphan Drug designation for Reolysin. Reolysin is the company’s lead...
7 years ago
Last Updated: 2 years ago
GW Pharmaceuticals reported top-line results from the first of three Phase 3 trials for Sativex.
8 years ago
Last Updated: 8 years ago
Analysts are beginning to make their calls for what the future will hold for Gilead Sciences, AbbVie and Express Scripts.
8 years ago
Last Updated: 8 years ago
AbbVie and Express Scripts have entered into an exclusive agreement under which Express Scripts will distribute AbbVie's hepatitis treatment.
8 years ago
Last Updated: 8 years ago
Array BioPharma has announced that it had reached a definitive agreement with Novartis to regain full worldwide rights to cancer drug binimetinib.
8 years ago
Last Updated: 8 years ago
Avanir Pharmaceuticals announced that it has entered into a definitive agreement with Otsuka Pharmaceutical for a $17.00 per share buyout.
8 years ago
Last Updated: 8 years ago
Source: U.S. Food & Drug AdministrationA purported herbal sexual health supplement called O.M.G. has been found by the U.S. Food and Drug Administration (FDA) to contain generic sildenafil, the...
8 years ago
Last Updated: 2 years ago
After markets closed last Friday, MannKind announced that the FDA had approved Afrezza, a rapid-acting, inhaled insulin powder that improves glycemic control in adults with diabetes.
8 years ago
Last Updated: 2 years ago
Source: ThinkstockThe U.S. Food and Drug Administration (FDA) late Friday afternoon announced that it has approved Afrezza, a rapid-acting, inhaled insulin power that improves glycemic control in...
8 years ago
Last Updated: 2 years ago
Shares of Sarepta Therapeutics went through the roof Monday morning following an announcement that it plans to have a New Drug Application filed with the FDA by the end of 2014 for its muscular...
8 years ago
Last Updated: 2 years ago
Usually when you see stocks double, it is based on a buyout or a major partnership development. That is not the case for Furiex Pharmaceuticals, which soared on news of positive top-line study...
8 years ago
Chelsea Therapeutics International is on the leader board for percentage gains on Thursday, with a rise of 111% or so. And it isn't even on news of a buyout. Can the company live up to its potential?
9 years ago
Source: ThinkstockAny time investors look for companies growing sales the most, one area that almost always stands out is the up and coming biotech stocks. After all, sales can grow from close to...
9 years ago
Last Updated: 9 years ago